Archive for December, 2008
Wednesday 31 December 2008 @ 5:58 pm
Charges were dismissed last week against a man suspected in an overdose death case.
Wednesday 31 December 2008 @ 5:48 pm
MONTREAL - Labopharm Inc. (TSX:DDS) says its flagship drug Ryzolt, a once-daily formulation of the painkiller tramadol, has been approved for sale
Wednesday 31 December 2008 @ 4:27 pm
WTOK-TV News Director John Johnson said he struggled through the marathon that he ran to raise awareness and money for cancer patients. "I hate running with a passion," he said. "But it was something that I thought I had to do, and it gave me a goal...
Wednesday 31 December 2008 @ 2:44 pm
Retail sales of Ranbaxy Laboratories, Cipla, Nicholas Piramal, Lupin and other drug makers have jumped by over 10 per cent in the domestic market despite the sales of generics or copycat versions of patented drugs falling in leading global markets such as the US and Europe.
Wednesday 31 December 2008 @ 2:16 pm
MONTREAL - Labopharm Inc. (TSX:DDS) says its flagship drug Ryzolt, a once-daily formulation of the painkiller tramadol, has been approved for sale
Wednesday 31 December 2008 @ 2:14 pm
Retail sales of Ranbaxy Laboratories, Cipla, Nicholas Piramal, Lupin and other drug makers have jumped by over 10 per cent in the domestic market despite the sales of generics or copycat versions of patented drugs falling in leading global markets such as the US and Europe.
Wednesday 31 December 2008 @ 1:49 pm
The company had an earlier recall in February
Wednesday 31 December 2008 @ 11:46 am
MONTREAL - Investors in Labopharm Inc. (TSX:DDS) held a New Year's Eve celebration after the U.S. Food and Drug Administration approved Ryzolt,
Wednesday 31 December 2008 @ 11:18 am
MONTREAL - Labopharm Inc. (TSX:DDS) says its flagship drug Ryzolt, a once-daily formulation of the painkiller tramadol, has been approved for sale in the world's biggest market for pharmaceuticals.
Wednesday 31 December 2008 @ 11:18 am
MONTREAL - Investors in Labopharm Inc. (TSX:DDS) held a New Year's Eve celebration after the U.S. Food and Drug Administration approved Ryzolt,


